Cancer Treatments With No Severe Side Effects

Platinum-based chemotherapy drug candidate trans,trans,trans-[Pt(N3)2(OH)2(py)2] study conducted by the Monash Warwick Alliance represented by various research groups from the University of Warwick and Monash University pioneered a new treatment option by triggering the cancer drug with infrared light. The resistance shown by the current cancer treatments make this light-activation cancer therapy, a turning point in the field of chemotherapy.